Thus,
upon activation by ActD, AKT becomes an inducer of p53 tumor suppression instead of being a
survival factor, as consistently shown in human embryonic kidney
cell lines (293 and 293T), human hepatoma
cell line (HepG2), and mouse hepatoma
cell line (Hepa - 1c1c7).